Research
Rigorous geroscience has produced genuinely promising results — rapamycin combinations extending mouse lifespan by ~27-29%, early senolytic human trials, and epigenetic reprogramming restoring tissue function in animal models — but the translational gap between these findings and human longevity remains vast, and a 2024 demographic analysis concluded that radical life extension this century is "implausible" without breakthroughs that do not yet exist. The core tension is not simply science versus hype: billionaire funding has accelerated legitimate research while simultaneously distorting priorities, amplifying contested claims (particularly around epigenetic reprogramming), and concentrating potential benefits among the wealthy — a concern underscored by the fact that Kerala, Rwanda, and Japan's social infrastructure investments have produced larger measurable longevity gains than any current biotech intervention. The honest verdict is that LEV in its strict actuarial sense remains speculative, meaningful healthspan extension is real and accelerating, and the most consequential question may not be whether we can outrun biological aging but who gets to, and at whose expense.
Life expectancy is typically defined in terms of what demographers call a period survival curve, which is a purely artificial construction derived from the ...
Longevity Escape Velocity (LEV) Foundation exists to address obstacles to the availability of treatments to prevent and reverse human age-related disease.
Overall, the ARDD 2025 meeting underscored a major turning point in the field. Aging research is no longer confined to observation—it is ...
Kirkland and AFAR experts have found it was possible to reduce the burden of senescent cells, and extend lifespan and improve health, even when treatment was ...
Bryan Johnson: The man who spent $10m to cheat death and age in reverse | Prof. Tim Spector · Comments.
This discussion finds that there are three clear classes (Tiers) of longevity systems that are currently under development, and all three will be paramount to ...
Lisa discusses SENS Research Foundation's plan for combating the multicausal process of aging and it's associated diseases by utilizing the ...
Achieving Longevity Escape Velocity Through Rejuvenation with Aubrey de Grey | May 15, 2025 · Comments.
We analyzed metabolomic differences in six organs of 12-month-old mice using five interventions leading to extended longevity.
This review aims to explore recent advancements in senolytics and senomorphics, their therapeutic potential, and the challenges in translating these strategies ...
Physical activity influences the cellular and molecular drivers of biological aging, slowing aging rates-a foundational aspect of geroscience.
Senolytics are agents that were originally developed using a hypothesis‐driven, mechanism‐based approach to target and eliminate senescent cells selectively: ...
Researchers at the Max Planck Institute have unveiled that combining trametinib with rapamycin, drugs used in cancer treatment, extends average lifespan by 29%.
Tech billionaire Peter Thiel has funneled millions into the field of longevity research. Peter Thiel, co-founder of PayPal, Palantir ...
These hallmarks are: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient-sensing, mitochondrial ...
Age reprogramming therapies aim to address the biological hallmarks of aging, including genomic instability, epigenetic alterations, mitochondrial dysfunction, ...
Here, we discuss aspects of NAD+ biosynthesis, together with putative mechanisms of NAD+ action against aging, including recent preclinical and clinical trials.
These data suggest that mouse models are not an accurate portrayal of what actually occurs in human inflammatory diseases.
These studies demonstrate how changes in telomere length may not only mirror the aging process but also potentially influence the onset and progression of age- ...
The term is meant as an analogy to the concept of escape velocity in physics, which is the minimum speed required for an object to indefinitely move away from a ...
Stem cell biologist discusses how his regenerative medicine predictions for 2025 turned out and what was surprising.
Leading demographers claim that human lifespan is fixed at a natural limit around 122 years. However, there is no fixed limit in animals.
An effective antiaging intervention might increase the mean and maximal human lifespan by about 40%, which is a mean age at death of about 112 years.
Ectopic expression of Yamanaka factors OCT4, SOX2, and KLF4 (OSK) restores youthful gene expression patterns, epigenetic age, and youthful functions to old ...
Their presence causes many problems: they degrade tissue function, increase levels of chronic inflammation, and can even eventually raise the risk of cancer.
Boston-based Life Biosciences plans 2026 human trials for gene therapy that could reverse cellular aging and restore tissue function. By Raphael ...
Billionaires funding science is not new, and it certainly isn't all bad, but President-elect Trump's calls to downsize government and ...
The results demonstrate that private and federal funding are not substitutes. Federal funding keeps researchers on an academic track.
Professor discusses how Charles Brenner has become arguably the most outspoken critic of longevity hype and David Sinclair.
Rapamycin may extend lifespan in old genetically heterogeneous mice through a combination of anti-neoplastic effects, and effects on cellular stress resistance ...
There is growing evidence that mTOR pathway activity accelerates aging and the development of age-related diseases including cancer ...
Moreover, metformin was shown to have a caloric restriction-related longevity benefit mediated by the activation of AMPK in C. elegans (64). Metformin also has ...
The debate between lifespan (the total number of years a person lives) and health span (the period of life free from chronic disease or disability)
By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase ...
New U.S. venture capital funds focused on slowing aging that raised $100 million or more included Korify Capital, Apollo Health Ventures, and the Maximon ...
Above age 105 human mortality appears constant over age at levels that are slowly declining across cohorts.
We also examine methods to induce senescence and discuss the distinction between chronological time and biological clock, with examples of ...
Epigenetic clocks, derived from DNA methylation patterns, have established themselves as powerful aging biomarkers, capable of estimating biological age and ...
By the end of 2025, many of these tailored neoantigen vaccines are moving aggressively into or completing pivotal Phase II trials, with major ...
While age reversal is an old grift, the latest version has reached new heights of feigned legitimacy and hype. Lifespan: Why We Age and Why We ...
Aging is thus a set of processes that occur within a complex system: in interacting networks structured by selection to maintain dynamic equilibrium, yet ...
The aim of this systematic review and meta-analysis was to update and synthesize the totality of research evidence related to the effectiveness ...
Biomarkers of Aging Conference 2025 convenes leading researchers, clinicians and industry in Boston to advance consensus on measuring aging.
This cross-sectional study quantifies the healthspan-lifespan gap around the world, assesses sex disparities, and analyzes associations with ...
This article reviews the broad topic of cellular senescence, how to manipulate it ‐ novel probes and nanocarriers have potential diagnostic and therapeutic ...
Sometimes I'm affraid of the possibility that SENS is overthrown by a similar but less efficient strategy, like the Hallmarks. It has happened ...
Join the 2025 Biomarkers of Aging Conference to explore cutting-edge research in geroscience, aging biomarkers, and longevity interventions.
These extensive preclinical studies were used to support the rapid translation of certain senolytics to human clinical trials. D+Q was the ...
5 Rather than aiming to slow aging, SENS seeks to reverse its effects, operating on the premise that repairing damage is more straightforward ...
Sign up to read the full research briefing
Sign up